{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:52:14Z","timestamp":1793890334737,"version":"4.8.0"},"reference-count":71,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Med Screen"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To review the existing evidence to identify the optimum methods for implementing human papillomavirus self-sampling to increase screening uptake for underserved groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Specific groups are less likely to participate in cervical screening. These include individuals from low socioeconomic status groups, ethnic minority groups, younger age groups (25\u201329), older age groups (\u226550), with a physical disability, with a learning disability and with an LGBTQ+ identity. The advent of human papillomavirus self-sampling for cervical screening presents an opportunity to promote equitable access to screening. Implementation for human papillomavirus self-sampling can vary, for example, opt-out or opt-in approaches. However, it is unclear which of these is the best method of offering human papillomavirus self-sampling to underserved groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Six databases were searched through May 2023. Studies comparing cervico-vaginal human papillomavirus self-sampling provision using different implementation strategies with the standard screening pathway in underserved groups were identified. A narrative synthesis was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 4574 studies were identified; 25 studies were included, of which 22 were from high-income countries. Greater uptake was found for offering human papillomavirus self-sampling compared to standard clinician-based sampling. Directly mailing human papillomavirus self-sampling kits to participants resulted in higher uptake of screening than using an \u2018opt-in\u2019 approach or standard recall in low socioeconomic status and ethnic minority groups, and older women. Strategies that used community health workers or educational materials increased uptake in ethnic minority and low socioeconomic status groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Directly mailing human papillomavirus self-sampling kits to low socioeconomic status groups, ethnic minority groups and older women has the potential to increase uptake of human papillomavirus self-sampling. Using community health workers to offer human papillomavirus self-sampling should be considered for ethnic minority and low socioeconomic status groups. Further research exploring the preferences of younger women is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09691413241274312","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T04:45:36Z","timestamp":1724993136000},"page":"2-18","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Identifying optimum implementation for human papillomavirus self-sampling in underserved communities: A systematic review"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3681-5807","authenticated-orcid":false,"given":"Olivia","family":"Mackay","sequence":"first","affiliation":[{"name":"School of Medicine, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate Joanna","family":"Lifford","sequence":"additional","affiliation":[{"name":"Division of Population Medicine, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahat","family":"Kalra","sequence":"additional","affiliation":[{"name":"School of Medicine, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denitza","family":"Williams","sequence":"additional","affiliation":[{"name":"Division of Population Medicine, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"bibr1-09691413241274312","unstructured":"Cancer Research UK. Cancer incidence by age, https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/incidence\/age#heading-Two (2021, accessed 4.3.2023)."},{"key":"bibr2-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.07.045"},{"key":"bibr3-09691413241274312","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2020.06.05"},{"key":"bibr4-09691413241274312","first-page":"240","volume":"2","author":"Nour NM","year":"2009","journal-title":"Rev Obstet Gynecol"},{"key":"bibr5-09691413241274312","unstructured":"UK Health Security Agency. HPV vaccination guidance for healthcare practitioners (version 6), https:\/\/www.gov.uk\/government\/collections\/hpv-vaccination-programme (2022, accessed 4.3.2023)."},{"key":"bibr6-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02178-4"},{"key":"bibr7-09691413241274312","unstructured":"Public Health England. Cervical screening: primary HPV screening implementation, https:\/\/www.gov.uk\/government\/publications\/cervical-screening-primary-hpv-screening-implementation (2019, accessed 13.11.2022)."},{"key":"bibr8-09691413241274312","unstructured":"NI Direct. Cervical screening, https:\/\/www.nidirect.gov.uk\/conditions\/cervical-cancer (accessed 24.10.2022)."},{"key":"bibr9-09691413241274312","unstructured":"Public Health Wales. Cervical screening Wales, https:\/\/phw.nhs.wales\/services-and-teams\/cervical-screening-wales\/what-is-cervical-screening\/ (accessed 24.10.2022)."},{"key":"bibr10-09691413241274312","unstructured":"NHS Inform Scotland. Cervical screening (smear test), https:\/\/www.nhsinform.scot\/healthy-living\/screening\/cervical\/cervical-screening-smear-test (2022, accessed 24.10.2022)."},{"key":"bibr11-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.290"},{"key":"bibr12-09691413241274312","volume":"363","author":"Arbyn M","year":"2018","journal-title":"Br Med J"},{"key":"bibr13-09691413241274312","volume":"9","author":"Costa S","journal-title":"Br J Cancer"},{"key":"bibr14-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3257939"},{"key":"bibr15-09691413241274312","unstructured":"Official statistics National statistics. Cervical screening programme 2017\u201318 [NS], https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/cervical-screening-annual\/england\u20142017-18 (2018, accessed 4.5.2023)."},{"key":"bibr16-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1002\/pon.4126"},{"key":"bibr17-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1258\/jms.2009.009073"},{"key":"bibr18-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2014-101082"},{"key":"bibr19-09691413241274312","unstructured":"Mackie A UHSA. Health matters: making cervical cancer screening more accessible, https:\/\/www.gov.uk\/government\/publications\/health-matters-making-cervical-screening-more-accessible\/health-matters-making-cervical-screening-more-accessible\u20132 (2017, accessed 24.10.2022)."},{"key":"bibr20-09691413241274312","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2020.0905"},{"key":"bibr21-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1177\/0969141315600192"},{"key":"bibr22-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1258\/jms.2010.010017"},{"key":"bibr23-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.04.017"},{"key":"bibr24-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-8-30"},{"key":"bibr25-09691413241274312","unstructured":"Cancer Research UK. Cervical screening, https:\/\/www.cancerresearchuk.org\/health-professional\/screening\/cervical-screening#Evidencecervical1 (accessed 15.10.2022)."},{"key":"bibr26-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003743"},{"key":"bibr27-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27790"},{"key":"bibr28-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2016-052609"},{"key":"bibr29-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001351"},{"key":"bibr30-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1177\/0969141314558785"},{"key":"bibr31-09691413241274312","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S288376"},{"key":"bibr32-09691413241274312","unstructured":"Bonde J. Self-sampling to reach non-participating women, https:\/\/www.hpvworld.com\/articles\/self-sampling-to-reach-non-participating-women\/ (accessed 30.10.2022)."},{"key":"bibr33-09691413241274312","unstructured":"European Cancer Organisation. Self-sampling and HPV screening in Europe: Position Paper, https:\/\/www.europeancancer.org\/policy\/13-policy\/27-self-sampling-and-hpv-screening-in-europe (2021, accessed 26.10.2022)."},{"key":"bibr34-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106900"},{"key":"bibr35-09691413241274312","doi-asserted-by":"crossref","unstructured":"Lim A, Deats K, Gambell J, et al. Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (Youscreen).\n                      Available at SSRN\n                      2023. DOI: dx.doi.org\/10.2139\/ssrn.4555189.","DOI":"10.2139\/ssrn.4555189"},{"key":"bibr36-09691413241274312","volume":"372","author":"Page MJ","year":"2021","journal-title":"Br Med J"},{"key":"bibr37-09691413241274312","unstructured":"Jo\u2019s cervical cancer trust. What is HPV self-sampling? https:\/\/www.jostrust.org.uk\/about-us\/news-and-blog\/blog\/what-hpv-self-sampling (2021, accessed 5.3.2023)."},{"key":"bibr38-09691413241274312","volume-title":"Guidance on the conduct of narrative synthesis in systematic reviews: a product of the ESRC methods programme","author":"Popay J","year":"2006"},{"key":"bibr39-09691413241274312","volume":"1","author":"Sterne JAC","year":"2019","journal-title":"The BMJ"},{"key":"bibr40-09691413241274312","volume":"355","author":"Sterne JA","year":"2016","journal-title":"Br Med J"},{"key":"bibr41-09691413241274312","unstructured":"Cochrane Scientific Committee. Review of the development of the risk of bias tool for nonrandomised studies for interventions \u2013 ROBINS-I, https:\/\/methods.cochrane.org\/sites\/methods.cochrane.org\/files\/uploads\/scientific_committee_statement_report_robins_i_fin.pdf (2017, accessed 17.4.2023)."},{"key":"bibr42-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.11.022"},{"key":"bibr43-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26128"},{"key":"bibr44-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c1040"},{"key":"bibr45-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2005.14.721"},{"key":"bibr46-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000430"},{"key":"bibr47-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(23)00076-2"},{"key":"bibr48-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-018-4404-z"},{"key":"bibr49-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2011.03.018"},{"key":"bibr50-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-018-1055-7"},{"key":"bibr51-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000424"},{"key":"bibr52-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.429"},{"key":"bibr53-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1177\/096914130601300409"},{"key":"bibr54-09691413241274312","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2021.0350"},{"key":"bibr55-09691413241274312","volume":"29","author":"Wedisinghe L","year":"2022","journal-title":"Prev Med Rep"},{"key":"bibr56-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1177\/0969141317696518"},{"key":"bibr57-09691413241274312","volume":"16","author":"Brewer N","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"bibr58-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.13285"},{"key":"bibr59-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25581"},{"key":"bibr60-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29176"},{"key":"bibr61-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30031"},{"key":"bibr62-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31391"},{"key":"bibr63-09691413241274312","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S164826"},{"key":"bibr64-09691413241274312","first-page":"2681","volume":"133","author":"Sancho-Garnier H","year":"2013","journal-title":"Int J Cancer"},{"key":"bibr65-09691413241274312","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19052610"},{"key":"bibr66-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1742642"},{"key":"bibr67-09691413241274312","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.935704"},{"key":"bibr68-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61522-5"},{"key":"bibr69-09691413241274312","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.07.006"},{"key":"bibr70-09691413241274312","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2022.23.3.767"},{"key":"bibr71-09691413241274312","unstructured":"National Institute for Health and Care Research (NIHR). Improving inclusion of under-served groups in clinical research: Guidance from INCLUDE project, https:\/\/www.nihr.ac.uk\/documents\/improving-inclusion-of-under-served-groups-in-clinical-research-guidance-from-include-project\/25435 (2020, accessed 17.4.2023)."}],"container-title":["Journal of Medical Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413241274312","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09691413241274312","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413241274312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:26:04Z","timestamp":1777677964000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09691413241274312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1177\/09691413241274312"],"URL":"https:\/\/doi.org\/10.1177\/09691413241274312","relation":{},"ISSN":["0969-1413","1475-5793"],"issn-type":[{"value":"0969-1413","type":"print"},{"value":"1475-5793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]}}}